| Lizenz: Creative Commons Namensnennung 4.0 International (797kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-383111
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.38311
Zusammenfassung
Background High-grade glioma (HGG) is associated with a limited prognosis. Drug repurposing has become of increasing interest to improve standard therapy. Statins and NSAIDs inhibit glioma cell growth in vitro and in vivo, but data on statin and NSAID treatment in relation to survival of patients with HGG are sparse. Methods We performed multivariable adjusted Cox-regression analyses among 1,093 ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags